MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
2020 · Nature Reviews Neurology · 259 citations
https://doi.org/10.1038/s41582-020-0314-x
C
Claudio Gasperini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
428
Papers
16.0K
Citations
64
h-index
241
i10-index
Claudio Gasperini is an academic researcher from Azienda Ospedaliera San Camillo-Forlanini. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Polyomavirus and related diseases & Peripheral Neuropathies and Disorders. The author has an h-index of 64, co-authored 364 publications.
ORCID: 0000-0002-3959-4067Papers by this author
worksEarly use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
2022 · Journal of Neurology · 170 citations
https://doi.org/10.1007/s00415-022-11193-w
Serum lactate as a novel potential biomarker in multiple sclerosis
2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 110 citations
https://doi.org/10.1016/j.bbadis.2014.04.005
A 6‐year clinical and MRI follow‐up study of patients with relapsing–remitting multiple sclerosis treated with Interferon‐beta
2002 · European Journal of Neurology · 68 citations
https://doi.org/10.1046/j.1468-1331.2002.00476.x
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study
2020 · Neurotherapeutics · 67 citations
https://doi.org/10.1007/s13311-020-00847-0
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis
2004 · Multiple Sclerosis Journal · 62 citations
https://doi.org/10.1191/1352458504ms1046oa
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat